Antares Pharma Inc
ATRS
Market Cap$0
Close$
$5.98
6.9% upside
Current Fair Value
6.9% upsideUndervalued by 6.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-42,822,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.23 |
| Beta | 0.0 |
| Outstanding Shares | 170,852,427 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 5.59 |
| Price to Book Ratio | 5.59 |
| Enterprise Value to Revenue | -0.23 |
| Enterprise Value to EBIT | -2.24 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -0.45 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
ESG Score
No data
About Antares Pharma Inc
CEO: Robert Apple Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Com...